Author

M. Tu

Institutions: Jiangsu Province Hospital, Nanjing Medical University

Observed institutions: Jiangsu Province Hospital, Nanjing Medical University

OpenAlex ID: A5017688159

2261eP A phase II study of NALIRIFOX in patients with locally advanced pancreatic cancer (LAPC)

2025 · D. Xu, N. Lu, et al. · Annals of Oncology

929P The efficacy and safety of surufatinib combined with chemotherapy in the first-line treatment of advanced periampullary carcinoma: A single arm, prospective, exploratory clinical study

2025 · Q. Wang, M. Tu, et al. · Annals of Oncology

1873P Thalidomide for the treatment of chemotherapy-induced night sweats in patients with pancreatic cancer

2024 · N. Lu, J. Zhu, et al. · Annals of Oncology

Subtypes of Pancreatic Ductal Adenocarcinoma Based on Senescence-Associated Secretory Phenotype and their Differing Survival Prognoses

2022 · J. Lin, P. Wu, et al. · HPB

Works count: 4

Citation count:

H-index:

I10-index: